OCT vs Fundus Photography in Optometry: Which Is Right for Your Practice?

Hitarth, B. Tech Computer Science & Engineering

• July 16, 2026 • 1 min read • 2 views

OCT vs Fundus Photography in Optometry: Which Is Right for Your Practice?

Optical coherence tomography (OCT) and fundus photography are the two most important diagnostic imaging modalities in optometry. Both have become standard of care in comprehensive eye exams, both are billable to medical insurance, and both provide clinical information the other cannot replicate. Yet many practices still approach these technologies as either/or choices due to equipment cost or space constraints. This guide explains what each does best, where they overlap, and how to build a clinical imaging program that uses both effectively.

What OCT Does That Fundus Photography Cannot

OCT produces cross-sectional, tomographic images of the retina and optic nerve — essentially a virtual biopsy of the tissue layers. This gives you information fundus photography simply cannot provide:

Retinal layer thickness measurements: RNFL thickness around the optic nerve and GCC thickness at the macula are the most sensitive structural markers for early glaucoma. Fundus photography shows the surface — OCT shows the layers beneath.
Macular anatomy: Drusen volume, subretinal fluid, intraretinal fluid, and epiretinal membrane are visible on OCT before they produce visible changes on fundus photography. For AMD and diabetic macular edema, OCT is indispensable.
Optic nerve head morphology: BMO-MRW (Bruch's membrane opening — minimum rim width) measured by OCT is a more sensitive glaucoma structural parameter than CDR estimated from fundus photos.
Quantitative trending: OCT software tracks layer thickness changes over time with statistical significance testing — enabling you to detect meaningful progression in individual patients.

What Fundus Photography Does That OCT Cannot

Fundus photography provides a color, wide-field view of the fundus that OCT cannot replicate:

Peripheral retina visibility: Standard OCT scans cover the central 6-12mm of the macula and a ring around the optic nerve. Ultra-widefield fundus photography (Optos, Zeiss Clarus) covers up to 200 degrees — revealing peripheral lattice degeneration, peripheral tears, vascular occlusions, and choroidal lesions that are outside the OCT scan area.
Hemorrhage and vascular documentation: Disc hemorrhages, cotton wool spots, flame hemorrhages, and arteriovenous changes are more visible and documentable on color fundus photography than on OCT.
Pigmentation patterns: Choroidal nevi, geographic atrophy boundaries, and RPE changes are often better characterized on color fundus images.
Patient communication: Color retinal photographs are highly effective for patient education — showing a diabetic patient their retinal photograph with hemorrhages marked is more impactful than an OCT thickness map for understanding their disease.
Population screening: For high-volume diabetic eye exam screening programs, automated fundus photography with AI analysis (IDx-DR, AEYE Health) is currently more practical than OCT for large-scale screening at the primary care level.

When to Use OCT, Fundus Photography, or Both

Glaucoma suspect / open-angle glaucoma: OCT (RNFL and optic nerve head) is the primary structural monitoring tool. Fundus photography serves as a complementary baseline document and for disc hemorrhage detection. Both at baseline; OCT primarily for follow-up.

Diabetic retinopathy screening: Fundus photography is the gold standard for DR grading. OCT is added when macular edema is suspected (the referral trigger for urgent ophthalmology evaluation). Both for patients with known DR; photography alone for initial DR screening.

Macular degeneration: OCT is primary — subretinal fluid detection is the key clinical finding driving treatment decisions. Wide-field fundus photography provides a useful baseline record and helps identify geographic atrophy extent. Both routinely for AMD patients.

Routine comprehensive exam in patients over 40: Non-mydriatic fundus photography at every visit. OCT on first visit in any patient with risk factors for glaucoma or macular disease, then as clinically indicated.

Building Your Imaging Program: Investment Considerations

For a practice adding imaging for the first time, a non-mydriatic fundus camera ($15,000-$22,000) provides the broadest clinical utility at the lowest entry price point and generates immediate medical billing revenue through CPT 92250. Add OCT (starting at $25,000 for a combined OCT/fundus system like the Topcon Maestro2) when your diabetic, glaucoma, and macular disease patient volume justifies it — typically when you have 10 or more patients per week who would benefit from OCT-level assessment. The combination generates significantly higher medical billing revenue and elevates the clinical depth of your practice above most independent OD competitors.

Frequently Asked Questions

Yes, in many circumstances. Both OCT (92132-92134) and fundus photography (92250) can be billed at the same visit when each is medically indicated and serves a distinct clinical purpose. For example, in a patient with AMD, fundus photography documents the color appearance and extent of geographic atrophy while OCT detects and quantifies subretinal fluid. Document the distinct clinical rationale for each imaging modality in your exam note to support the separate claim for each code.

Both provide wide-field retinal imaging, but use different technologies. Optos uses scanning laser ophthalmoscopy with an ellipsoidal mirror to capture up to 200 degrees of peripheral retina in a single image without dilation. Zeiss Clarus uses a high-resolution LED fundus camera that captures true-color images up to 133 degrees (Clarus 500) or 133-200 degrees with montage (Clarus 700). Optos has greater peripheral reach; Zeiss Clarus has superior central image quality and true color rendering. The best choice depends on your clinical priorities and patient population.

No. OCT is billable to medical insurance when there is a specific medical indication documented in the record — glaucoma, diabetic retinopathy, macular degeneration, epiretinal membrane, and similar conditions. Performing OCT as a routine screening test on every patient without a documented medical indication is not supported by most payer policies and can trigger billing audits. Patient charges for screening OCT without a medical indication should be collected directly from the patient as a non-covered service, with appropriate patient notification.

For a stable glaucoma suspect or early open-angle glaucoma patient on treatment, OCT every 12 months is typical. For patients with moderate-to-advanced glaucoma or suspected rapid progressors, every 6 months. For a newly diagnosed glaucoma suspect establishing baseline, two OCT scans within the first 6 months provides better statistical reliability for future trend analysis than a single baseline. Heidelberg and Zeiss both provide AI-assisted trend analysis that improves its statistical power with each additional scan.